{"id":"riastap","safety":{"commonSideEffects":[{"rate":null,"effect":"Thromboembolism"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Allergic reactions"}]},"_chembl":null,"_dailymed":{"setId":"903dc8d0-39da-462c-9dac-004e0c7a26cc","title":"RIASTAP (FIBRINOGEN HUMAN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION RIASTAP (FIBRINOGEN HUMAN) INJECTION, SOLUTION [CSL BEHRING GMBH]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"RiaSTAP provides exogenous fibrinogen (Factor I), a critical blood clotting protein, to patients with congenital or acquired fibrinogen deficiency or dysfunction. Fibrinogen is essential for thrombin-mediated clot formation and platelet aggregation. By restoring fibrinogen levels, the drug enables normal hemostasis and reduces bleeding risk in deficient patients.","oneSentence":"RiaSTAP is a fibrinogen concentrate that replaces or supplements fibrinogen to restore clotting ability in patients with fibrinogen deficiency.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:05:06.817Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Congenital fibrinogen deficiency (afibrinogenemia or hypofibrinogenemia)"},{"name":"Acquired fibrinogen deficiency"}]},"trialDetails":[{"nctId":"NCT06617897","phase":"PHASE3","title":"Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery","status":"RECRUITING","sponsor":"CSL Behring","startDate":"2024-10-01","conditions":"Acquired Fibrinogen Deficiency","enrollment":90},{"nctId":"NCT04376762","phase":"PHASE4","title":"Comparison of Fibrinogen Concentrate and Cryoprecipitate in Pediatric Cardiac Surgery Patients","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2021-10-26","conditions":"Pediatric HD, Bleeding","enrollment":31},{"nctId":"NCT05385952","phase":"NA","title":"GATT-Patch Versus TachoSil in Liver Surgery","status":"COMPLETED","sponsor":"GATT Technologies BV","startDate":"2022-08-04","conditions":"Intraoperative Bleeding, Hemorrhage, Surgical, Liver Diseases","enrollment":132},{"nctId":"NCT05449834","phase":"PHASE3","title":"Fibrinogen Early In Severe Trauma StudY II","status":"RECRUITING","sponsor":"Australian and New Zealand Intensive Care Research Centre","startDate":"2022-11-21","conditions":"Trauma, Haemorrhagic Shock, Coagulopathy","enrollment":900},{"nctId":"NCT05091684","phase":"PHASE2","title":"Administration of Fibrinogen Concentrate for Refractory Bleeding","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2022-02-10","conditions":"Hematological Patients, Bleeding, Platelet Refractoriness","enrollment":1},{"nctId":"NCT07216157","phase":"NA","title":"NoSeal Trial: Comparing Sealants Versus No Sealant for Preventing CSF Leak After Endonasal Skull Base Surgery","status":"RECRUITING","sponsor":"Maria Sklodowska-Curie National Research Institute of Oncology","startDate":"2025-08-15","conditions":"CerebroSpinal Fluid (CSF) Leak","enrollment":225},{"nctId":"NCT02065882","phase":"PHASE3","title":"Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency","status":"COMPLETED","sponsor":"Biotest","startDate":"2013-03","conditions":"Congenital Afibrinogenemia, Congenital Hypofibrinogenemia","enrollment":67},{"nctId":"NCT03444324","phase":"PHASE3","title":"Adjusted Fibrinogen Replacement Strategy","status":"COMPLETED","sponsor":"Biotest","startDate":"2018-04-03","conditions":"Bleeding Disorder, Hypofibrinogenemia; Acquired","enrollment":222},{"nctId":"NCT04660721","phase":"PHASE1, PHASE2","title":"A Study Evaluating the Safety and Preliminary Efficacy of sFilm-FS in Controlling Parenchymal Bleeding During Elective Hepatic Surgery","status":"COMPLETED","sponsor":"Sealantium Medical Ltd.","startDate":"2021-05-12","conditions":"Hemostasis, General Surgery","enrollment":33},{"nctId":"NCT04602689","phase":"NA","title":"Fibrin Glue After ESD for High Risk Patients of Bleeding","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2020-10-30","conditions":"Early Gastric Cancer, Gastric Adenoma","enrollment":134},{"nctId":"NCT05780125","phase":"PHASE2","title":"Effectiveness of Different Fibrinogen Preparations in Restoring Clot Firmness","status":"COMPLETED","sponsor":"IRCCS Policlinico S. Donato","startDate":"2023-03-20","conditions":"Hypofibrinogenemia, Surgical Blood Loss, Bleeding","enrollment":40},{"nctId":"NCT03932240","phase":"PHASE3","title":"In Vivo Effects of Fibrinogen Concentrate (FC) Versus Cryoprecipitate on the Neonatal Fibrin Network Structure After Cardiopulmonary Bypass (CPB)","status":"COMPLETED","sponsor":"Emory University","startDate":"2019-08-13","conditions":"Hemostasis","enrollment":36},{"nctId":"NCT03780894","phase":"PHASE1, PHASE2","title":"Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage at Pre-hospital Phase of Care.","status":"COMPLETED","sponsor":"Banc de Sang i Teixits","startDate":"2018-11-21","conditions":"Polytrauma, Traumatic Hemorrhage","enrollment":79},{"nctId":"NCT02227992","phase":"PHASE3","title":"The EVARREST® Paediatric Mild/Moderate Liver and Soft Tissue Bleeding Study","status":"COMPLETED","sponsor":"Ethicon, Inc.","startDate":"2014-07-01","conditions":"Hemorrhage, Soft Tissue Bleeding, Hepatic Parenchyma Bleeding","enrollment":40},{"nctId":"NCT05986201","phase":"","title":"Assessment of Long-term Effects of Tachosil","status":"COMPLETED","sponsor":"University of Catania","startDate":"2016-02-01","conditions":"Fibrin Sealant, Haemostasis","enrollment":40},{"nctId":"NCT05831267","phase":"NA","title":"Fibrin Glue Versus Titanium Platelet-rich Fibrin in Lateral Sinus Lifting","status":"COMPLETED","sponsor":"Hams Hamed Abdelrahman","startDate":"2022-02-01","conditions":"Sinus Floor Augmentation, Graftless Sinus Elevation","enrollment":30},{"nctId":"NCT03461406","phase":"PHASE3","title":"A Study of Safety and Efficacy of Fibrin Sealant Grifols as an Adjunct to Haemostasis During Surgery in Paediatric Participants","status":"COMPLETED","sponsor":"Instituto Grifols, S.A.","startDate":"2019-01-18","conditions":"Excessive Bleeding During Surgery","enrollment":186},{"nctId":"NCT05391412","phase":"PHASE4","title":"Effect of Prophylactic Fibrinogen Concentrate In Scoliosis Surgery","status":"UNKNOWN","sponsor":"Brno University Hospital","startDate":"2022-06-06","conditions":"Fibrinogen, Spine Deformity, Coagulopathy, Consumption","enrollment":32},{"nctId":"NCT05490940","phase":"NA","title":"Sensory Recovery of Digital Nerves After Microsurgical Epineural Neurorrhaphy Alone or in Combination With Tisseel - RET","status":"UNKNOWN","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2023-03-01","conditions":"Digital Nerve Injuries","enrollment":74},{"nctId":"NCT05717335","phase":"","title":"Observational Pilot Study With TachoSil as a Ventricular Sealant","status":"COMPLETED","sponsor":"Germans Trias i Pujol Hospital","startDate":"2022-05-01","conditions":"Intraventricular Neoplasm","enrollment":20},{"nctId":"NCT00916656","phase":"PHASE3","title":"Fibrinogen Concentrate (Human) - Efficacy and Safety Study","status":"WITHDRAWN","sponsor":"CSL Behring","startDate":"2009-10","conditions":"Afibrinogenemia, Hypofibrinogenemia, Fibrinogen Deficiency","enrollment":""},{"nctId":"NCT04405518","phase":"PHASE4","title":"Impact of Two Guided Transfusion Strategies on Blood Product Requirements in Liver Transplantation.","status":"UNKNOWN","sponsor":"Antoni Sabaté Pes","startDate":"2019-06-17","conditions":"Fibrin Blood Clot","enrollment":188},{"nctId":"NCT04434001","phase":"PHASE2","title":"ZEPLAST- PED: ZEro_PLASma Trial in Small Infants Undergoing Cardiac Surgery","status":"TERMINATED","sponsor":"IRCCS Policlinico S. Donato","startDate":"2020-02-27","conditions":"Bleeding, Cardiac Defect, Surgery--Complications","enrollment":40},{"nctId":"NCT02822599","phase":"PHASE4","title":"Human Fibrinogen Concentrate in Pediatric Cardiac Surgery","status":"COMPLETED","sponsor":"Nicklaus Children's Hospital f/k/a Miami Children's Hospital","startDate":"2017-06-01","conditions":"Hypofibrinogenemia, Afibrinogenemia, Bleeding Disorders","enrollment":30},{"nctId":"NCT03784794","phase":"NA","title":"Patient Blood Management for Massive Obstetric Hemorrhage","status":"COMPLETED","sponsor":"Angel Augusto Perez Calatayud","startDate":"2018-11-01","conditions":"Post Partum Hemorrhage, Fibrinogenolysis; Hemorrhage, Fibrinogen; Deficiency, Acquired","enrollment":100},{"nctId":"NCT02528708","phase":"PHASE1, PHASE2","title":"A Program to Evaluate Riastap® and FIBTEM® for the Early Control and Treatment of Postpartum Hemorrhage (PERFECT PPH)","status":"WITHDRAWN","sponsor":"Yale University","startDate":"2021-01","conditions":"Postpartum Hemorrhage","enrollment":""},{"nctId":"NCT02155725","phase":"PHASE4","title":"Fibrinogen in Haemorrhage of Delivery","status":"COMPLETED","sponsor":"Laboratoire français de Fractionnement et de Biotechnologies","startDate":"2014-04-10","conditions":"Post-Partum Hemorrhage","enrollment":448},{"nctId":"NCT04317924","phase":"NA","title":"Pneumostasis With Use of Bio-absorbable Mesh and Fibrin Sealant in Lung Resection","status":"WITHDRAWN","sponsor":"Boston Medical Center","startDate":"2020-10","conditions":"Air Leak From Lung","enrollment":""},{"nctId":"NCT03508141","phase":"PHASE2","title":"Fibrinogen Early In Severe Trauma studY Junior","status":"UNKNOWN","sponsor":"Gold Coast Hospital and Health Service","startDate":"2018-07-01","conditions":"Trauma, Hemorrhage, Coagulopathy","enrollment":44},{"nctId":"NCT01623531","phase":"PHASE3","title":"Prospective Double Blinded Randomized Control Study of the Use of Fibrinogen in High-Risk Cardiac Surgery","status":"COMPLETED","sponsor":"Nova Scotia Health Authority","startDate":"2014-02","conditions":"Cardiac Complication During Procedure","enrollment":62},{"nctId":"NCT02685007","phase":"","title":"RollOut -Pre-Rolled TachoSil in Laparoscopic Utilisation. A Non-Interventional Study","status":"COMPLETED","sponsor":"Takeda","startDate":"2016-04-05","conditions":"Laparoscopy","enrollment":131},{"nctId":"NCT03183479","phase":"PHASE4","title":"The Effects of Fibrinogen Concentrate Infusion on Blood Loss and Allogeneic Blood Conservation in Scoliosis Surgery","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2017-06-14","conditions":"Scoliosis; Adolescence, Bleeding, Surgery","enrollment":102},{"nctId":"NCT01527357","phase":"PHASE3","title":"A Study of Fibrocaps™ in Surgical Bleeding","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2012-05-21","conditions":"Mild or Moderate Surgical Bleeding","enrollment":721},{"nctId":"NCT02311543","phase":"PHASE3","title":"Impact of a Surgical Sealing Patch on Lymphatic Drainage After ALND for Breast Cancer","status":"COMPLETED","sponsor":"Swiss Cancer Institute","startDate":"2015-03-18","conditions":"Breast Cancer","enrollment":142},{"nctId":"NCT03304899","phase":"PHASE1, PHASE2","title":"Fibrinogen Concentrate in Isolated Traumatic Brain Injury","status":"UNKNOWN","sponsor":"Leila Dehghani","startDate":"2018-10-23","conditions":"Traumatic Brain Injury, Hemorrhage","enrollment":50},{"nctId":"NCT02540434","phase":"NA","title":"Trial of RiaSTAP Versus Cryoprecipitate to Lower Operative Transfusions","status":"TERMINATED","sponsor":"Weill Medical College of Cornell University","startDate":"2015-10","conditions":"Coagulopathy","enrollment":19},{"nctId":"NCT01910675","phase":"PHASE4","title":"PCC and Fibrinogen Compared With FFP in PPH","status":"WITHDRAWN","sponsor":"Helsinki University Central Hospital","startDate":"2013-07","conditions":"Postpartum Haemorrhage","enrollment":""},{"nctId":"NCT01283321","phase":"PHASE2","title":"RiaSTAP vs. Conventional Transfusion in Patients Having Heart Valve Surgery","status":"TERMINATED","sponsor":"Emory University","startDate":"2011-01","conditions":"Heart Valve Disease, Coronary Artery Disease","enrollment":26},{"nctId":"NCT01681030","phase":"PHASE2","title":"The Fibrin Pad Cardiovascular Study","status":"COMPLETED","sponsor":"Ethicon, Inc.","startDate":"2012-08-01","conditions":"Cardiovascular Disease","enrollment":42},{"nctId":"NCT01575756","phase":"PHASE2","title":"Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap","status":"COMPLETED","sponsor":"Octapharma","startDate":"2013-06","conditions":"Congenital Fibrinogen Deficiency, Afibrinogenemia","enrollment":22},{"nctId":"NCT02745041","phase":"PHASE2","title":"Fibrinogen Early In Severe Trauma studY","status":"COMPLETED","sponsor":"Gold Coast Hospital and Health Service","startDate":"2016-12","conditions":"Trauma, Haemorrhage, Coagulopathy","enrollment":100},{"nctId":"NCT01902459","phase":"PHASE4","title":"EVARREST™ Fibrin Sealant Patch Post-Market Study","status":"COMPLETED","sponsor":"Ethicon, Inc.","startDate":"2013-07-01","conditions":"Hemorrhage, Soft Tissue Bleeding","enrollment":150},{"nctId":"NCT02427217","phase":"","title":"An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency","status":"COMPLETED","sponsor":"CSL Behring","startDate":"2015-05-07","conditions":"Congenital Fibrinogen Deficiency","enrollment":22},{"nctId":"NCT02284256","phase":"PHASE3","title":"A Safety and Efficacy Study Comparing Fibrocaps and Tachosil in Hepatic Surgery","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2014-11","conditions":"Surgical Bleeding","enrollment":150},{"nctId":"NCT02040428","phase":"PHASE3","title":"The Fibrin Pad CV Phase III Study","status":"COMPLETED","sponsor":"Ethicon, Inc.","startDate":"2014-01-01","conditions":"Cardiovascular Disease","enrollment":156},{"nctId":"NCT02344069","phase":"PHASE2","title":"Pilot Randomized Trial of Fibrinogen in Trauma Haemorrhage","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2015-02","conditions":"Trauma, Haemorrhage","enrollment":40},{"nctId":"NCT01500135","phase":"PHASE3","title":"Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery","status":"COMPLETED","sponsor":"Takeda","startDate":"2012-03","conditions":"Bleeding","enrollment":150},{"nctId":"NCT01920958","phase":"","title":"Use of Tachosil® for Lymph Sealing During Surgery","status":"COMPLETED","sponsor":"Takeda","startDate":"2012-09","conditions":"Lymph Node Resection","enrollment":233},{"nctId":"NCT02416817","phase":"PHASE4","title":"Strategy of Transfusion in Trauma Patients - STATA Trial","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2014-07","conditions":"Wounds and Injuries","enrollment":156},{"nctId":"NCT00496262","phase":"PHASE2","title":"Human Fibrinogen - Pharmacokinetics","status":"COMPLETED","sponsor":"CSL Behring","startDate":"2007-07","conditions":"Fibrinogen Deficiency","enrollment":15},{"nctId":"NCT01993888","phase":"PHASE3","title":"The EVARREST® Fibrin Sealant Patch Liver Study","status":"COMPLETED","sponsor":"Ethicon, Inc.","startDate":"2013-10","conditions":"Hemorrhage","enrollment":102},{"nctId":"NCT01550406","phase":"PHASE4","title":"Use of Polyethylene Glycolic Acid or Tachocomb to Prevent Pancreatic Fistula Following Distal Pancreatectomy","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2011-11","conditions":"Pancreatic Fistula","enrollment":150},{"nctId":"NCT02203968","phase":"PHASE1, PHASE2","title":"Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST)","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2014-10","conditions":"Trauma, Injury, Bleeding","enrollment":50},{"nctId":"NCT01955811","phase":"PHASE4","title":"Study to Reveal if Fibrinogen Treatment Effects Blood Clotting Better Than a Platelet Transfusion","status":"COMPLETED","sponsor":"Medical University Innsbruck","startDate":"2012-12","conditions":"Blood Platelet Transfusion, Blood Clotting","enrollment":130},{"nctId":"NCT02094430","phase":"PHASE2, PHASE3","title":"Human Fibrinogen Concentrate (FGTW) in Pediatric Patients With Congenital Fibrinogen Deficiency","status":"COMPLETED","sponsor":"Laboratoire français de Fractionnement et de Biotechnologies","startDate":"2014-01","conditions":"Hypofibrinogenemia, Congenital, Afibrinogenemia, Congenital","enrollment":16},{"nctId":"NCT01475344","phase":"PHASE1, PHASE2","title":"Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC)","status":"COMPLETED","sponsor":"Medical University Innsbruck","startDate":"2011-09","conditions":"Trauma, Massive Hemorrhage","enrollment":67},{"nctId":"NCT00977925","phase":"PHASE3","title":"The Severe Soft Tissue Bleeding Study","status":"COMPLETED","sponsor":"Ethicon, Inc.","startDate":"2009-08","conditions":"Soft Tissue Bleeding","enrollment":91},{"nctId":"NCT00968045","phase":"PHASE2","title":"Fibrinogen and Bleeding After Cardiac Surgery","status":"COMPLETED","sponsor":"Sahlgrenska University Hospital","startDate":"2009-04","conditions":"Complications, Bleeding, Coronary Artery Disease","enrollment":52},{"nctId":"NCT02105506","phase":"NA","title":"Safety and Feasibility of TachoSil®: Application on Esophageal Anastomoses","status":"COMPLETED","sponsor":"R. van Hillegersberg","startDate":"2012-09","conditions":"Esophageal Disease, Gastric Disease","enrollment":15},{"nctId":"NCT01471730","phase":"PHASE3","title":"The ZEro PLASma Trial (ZEPLAST): Avoidance of Fresh Frozen Plasma in Cardiac Surgery","status":"COMPLETED","sponsor":"IRCCS Policlinico S. Donato","startDate":"2011-11","conditions":"Heart Disease","enrollment":119},{"nctId":"NCT01300286","phase":"PHASE4","title":"Open Label Use Of RiaStap During Aortic Reconstruction","status":"COMPLETED","sponsor":"Duke University","startDate":"2010-12","conditions":"Coagulopathic Bleeding","enrollment":23},{"nctId":"NCT01539057","phase":"PHASE3","title":"The Efficacy of the Administration of Fibrinogen in Liver Transplantation","status":"UNKNOWN","sponsor":"Hospital Universitari de Bellvitge","startDate":"2012-07","conditions":"Intraoperative Bleeding","enrollment":132},{"nctId":"NCT01487837","phase":"PHASE4","title":"Fibrinogen for Treatment of Pediatric Dilutional Coagulopathy. FibPaed Study.","status":"COMPLETED","sponsor":"University Children's Hospital, Zurich","startDate":"2012-01","conditions":"Blood Coagulation Disorders, Hemorrhage","enrollment":57},{"nctId":"NCT01475669","phase":"PHASE3","title":"Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery","status":"COMPLETED","sponsor":"CSL Behring","startDate":"2012-01","conditions":"Surgical Blood Loss, Postoperative Blood Loss","enrollment":152},{"nctId":"NCT00658723","phase":"PHASE2","title":"The Fibrin Patch Soft Tissue Study","status":"COMPLETED","sponsor":"Ethicon, Inc.","startDate":"2008-03","conditions":"Hemostasis","enrollment":141},{"nctId":"NCT01166243","phase":"PHASE3","title":"The Fibrin Pad Liver Study","status":"COMPLETED","sponsor":"Ethicon, Inc.","startDate":"2010-07","conditions":"Hemorrhage","enrollment":84},{"nctId":"NCT01235715","phase":"PHASE4","title":"The Use of Evicel to Reduce Blood Loss in Total Knee Replacement Surgery","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2010-09","conditions":"Osteoarthritis","enrollment":200},{"nctId":"NCT00701142","phase":"PHASE2","title":"Haemocomplettan® P During Aortic Replacement","status":"COMPLETED","sponsor":"CSL Behring","startDate":"2008-06","conditions":"Aortic Aneurysm","enrollment":80},{"nctId":"NCT00241163","phase":"PHASE3","title":"TachoComb S Versus Standard Surgical Treatment in Surgical Resection of Renal Tumour (TC-015-IN)","status":"COMPLETED","sponsor":"Takeda","startDate":"","conditions":"Surgical Resection of Superficial Renal Tumour","enrollment":170},{"nctId":"NCT00713661","phase":"PHASE2","title":"Evaluation of TachoSil® Application on a Colorectal Anastomosis (TC-029-IM)","status":"COMPLETED","sponsor":"Nycomed","startDate":"2008-06","conditions":"Colorectal Anastomosis","enrollment":25},{"nctId":"NCT00440401","phase":"PHASE4","title":"TachoSil® Versus Standard Haemostatic Treatment of Haemorrhage in Cardiovascular Surgery (TC-023-IM)","status":"COMPLETED","sponsor":"Nycomed","startDate":"2007-02","conditions":"Haemorrhage, Haemostasis, Cardiovascular Surgery","enrollment":120},{"nctId":"NCT00290836","phase":"PHASE4","title":"Assess Efficacy and Safety of TachoComb H vs. Standard Surgical Treatment (i.e. Suturing) in Patients Undergoing Prostatectomy (TC-017-AU)","status":"COMPLETED","sponsor":"Nycomed","startDate":"2004-05","conditions":"Control of Local Bleeding in Patients Undergoing Prostatectomy.","enrollment":120},{"nctId":"NCT00293514","phase":"PHASE3","title":"TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM)","status":"COMPLETED","sponsor":"Nycomed","startDate":"2006-02","conditions":"Pulmonary Diseases, Intraoperative Complications","enrollment":""},{"nctId":"NCT00279383","phase":"","title":"OSHES - Observational Study on Hemostasis in Surgery (TC-022-IT)","status":"COMPLETED","sponsor":"Nycomed","startDate":"2005-08","conditions":"Blood Loss, Surgical, Hemostasis","enrollment":800},{"nctId":"NCT00365248","phase":"PHASE3","title":"TachoSil Paediatric Liver Trial (TC-019-IN)","status":"COMPLETED","sponsor":"Nycomed","startDate":"2005-10","conditions":"Liver Diseases","enrollment":16},{"nctId":"NCT00285623","phase":"","title":"Observational Cohort Study of TachoSil (TC-018-IN)","status":"COMPLETED","sponsor":"Nycomed","startDate":"2005-12","conditions":"Blood Loss, Surgical","enrollment":3000},{"nctId":"NCT00546169","phase":"","title":"Non-interventional Trial About Treatment of Haemorrhages in Cholecystectomy With TachoSil (TC-027-DE)","status":"COMPLETED","sponsor":"Nycomed","startDate":"2007-06","conditions":"Hemorrhage","enrollment":500},{"nctId":"NCT00983112","phase":"PHASE4","title":"Evicel Study on the Peri-operative Bleeding in Total Knee Prothesis Surgery","status":"UNKNOWN","sponsor":"Clinique Mutualiste Chirurgicale de la Loire","startDate":"2009-09","conditions":"Thrombosis","enrollment":116},{"nctId":"NCT00307515","phase":"PHASE3","title":"Evaluation of Fibrin Sealant 2 in Retroperitoneal or Intra-Abdominal Surgery","status":"COMPLETED","sponsor":"Ethicon, Inc.","startDate":"2006-02","conditions":"Blood Loss, Surgical","enrollment":135}],"_emaApprovals":[],"_faersSignals":[{"count":33,"reaction":"NO ADVERSE EVENT"},{"count":23,"reaction":"OFF LABEL USE"},{"count":10,"reaction":"PRODUCT USE IN UNAPPROVED INDICATION"},{"count":9,"reaction":"PYREXIA"},{"count":8,"reaction":"DYSPNOEA"},{"count":7,"reaction":"DRUG INEFFECTIVE"},{"count":6,"reaction":"CEREBROVASCULAR ACCIDENT"},{"count":6,"reaction":"HYPOTENSION"},{"count":5,"reaction":"HAEMORRHAGE"},{"count":5,"reaction":"PULMONARY OEDEMA"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Concentrated Fibrinogen","Fibrinogen Concentrate Human","Human Fibrinogen concentrate"],"phase":"marketed","status":"active","brandName":"RiaSTAP","genericName":"RiaSTAP","companyName":"Weill Medical College of Cornell University","companyId":"weill-medical-college-of-cornell-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"RiaSTAP is a fibrinogen concentrate that replaces or supplements fibrinogen to restore clotting ability in patients with fibrinogen deficiency. Used for Congenital fibrinogen deficiency (afibrinogenemia or hypofibrinogenemia), Acquired fibrinogen deficiency.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}